Recent Posts
- The Hidden Threat to AAV Purity: Uncovering Ferritin Contamination
- [1/17/2025] Gene and Cell Therapy- weekly digest from PackGene
- Umoja secures $100m to advance CAR-T cell therapy pipeline
- Kyverna Focuses on Autoimmune CAR-T Therapies and Key Strategic Priorities
- Inspector General questions FDA’s accelerated approval for Biogen, Sarepta drugs
AAV One-stop Solution
Tags
AAV2
AAV5
AAV based gene therapy
AAV Capsid
ALS
Alzheimer’s Disease
brain vasculature
cancer
CAR-T
Cell Therapy
COVID-19
COVID vaccine
CRISPR
CRISPR/Cas
Drug Development
dystrophin
eye disease
FDA
gene editing
gene therapy
genetic engineering
genome editing
GMP plasmid
hearing
heart disease
hemophilia
Hemophilia B
hepatitis research
HIV
immunotherapy
liver cancer
mRNA
Neurodegenerative Diseases
Orphan Drug
Parkinson
rare disease
Retinoschisis
RNA
RNAi therapeutics
RNA vaccines
SARS-CoV-2
Sickle Cell Disease
SMA Treatment
thyroid
zolgensma